Anti-Human KIR3DL2 Therapeutic Antibody (IPH41)
Recombinant Humanized monoclonal antibody expressed in CHO binding to Human KIR3DL2. IPH41 is a humanized cytotoxic antibody (IgG1) which targets and destroys cells expressing KIR3DL2. KIR3DL2 is an inhibitory receptor of the KIR family, normally expressed on a fraction of normal NK cells but specifically expressed in most subtypes of the orphan indication of cutaneous T-cell lymphomas (CTCL). CTCL is a group of rare cutaneous lymphomas of T lymphocytes with poor prognosis and few therapeutic options at advanced stages.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-469CL |
Pricing | Inquiry |
Type | Antibody |
Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |
Target | KIR3DL2 |
Species Reactivity | Human |